Literature DB >> 18177421

CD2-associated protein is widely expressed and differentially regulated during embryonic development.

Sanna Lehtonen1, Jukka Tienari, Anou Londesborough, Ulla Pirvola, Ari Ora, Ilkka Reima, Eero Lehtonen.   

Abstract

CD2-associated protein (CD2AP) is an adapter protein that is involved in various signaling and vesicular trafficking processes and also functions as a linker between plasma membrane proteins and the actin cytoskeleton. The protein is known to have important functions in T cells and glomerular podocytes, but it is also expressed by many other adult-type tissues and cells. Here we analyzed the expression of the protein during early embryonic development and organogenesis of the mouse. The results showed differential tissue-specific regulation of CD2AP in developing and maturing organs. In oocytes and pre-implantation embryos, CD2AP was located diffusely in the cytoplasm, whereas in late blastocysts it was concentrated to the intercellular contacts. During organogenesis, CD2AP was distinctly upregulated upon, e.g., the pretubular aggregation of metanephric mesenchyme cells and the appearance of the osteoblastic rim around cartilages during endochondral ossification. High CD2AP expression was also observed during epithelial-like conversion of some highly specialized secretory cell types such as the odontoblasts, the cells of the choroid plexus and the decidualized cells of the endometrial stroma. In other instances, such as the development of the proximal tubuli of the kidney and the flat alveolar epithelium of the lung, the protein was downregulated upon differentiation and maturation of the cells. Finally, certain cells, e.g., glomerular podocytes, those forming the collecting ducts of the kidney, and the urothelium of the kidney pelvis, expressed CD2AP throughout their differentiation and maturation. Multiple molecules and complex pathways regulate embryogenesis, and scaffolding proteins apparently have pivotal roles in targeting and finetuning, e.g., growth factor- or hormone-induced processes. The cell-type specific spatio-temporal regulation of CD2AP during development suggests that this adapter protein is a key regulatory partner in many signaling pathways and cellular processes governing differentiation and morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177421     DOI: 10.1111/j.1432-0436.2007.00255.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

1.  The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity.

Authors:  J Nicholas Cochran; Travis Rush; Susan C Buckingham; Erik D Roberson
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

2.  Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.

Authors:  Chun Zhang; Min Xia; Krishna M Boini; Cai-Xia Li; Justine M Abais; Xiao-Xue Li; Laura A Laperle; Pin-Lan Li
Journal:  Pflugers Arch       Date:  2011-06-07       Impact factor: 3.657

Review 3.  Detrimental effects of hypoxia on glomerular podocytes.

Authors:  Ashish K Singh; Lakshmi P Kolligundla; Justus Francis; Anil K Pasupulati
Journal:  J Physiol Biochem       Date:  2021-04-09       Impact factor: 4.158

4.  Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP.

Authors:  Jin Yu; Nina Sheung; Elwy M Soliman; Carlo Spirli; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

5.  CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction.

Authors:  Cynthia C Tsui; Brian A Pierchala
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

6.  Septin 7 forms a complex with CD2AP and nephrin and regulates glucose transporter trafficking.

Authors:  Anita A Wasik; Zydrune Polianskyte-Prause; Meng-Qiu Dong; Andrey S Shaw; John R Yates; Marilyn G Farquhar; Sanna Lehtonen
Journal:  Mol Biol Cell       Date:  2012-07-18       Impact factor: 4.138

7.  Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.

Authors:  Krishna M Boini; Min Xia; Jing Xiong; Caixia Li; Lori P Payne; Pin-Lan Li
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

8.  Does nephrotic syndrome without chronic kidney disease increase the risk of Parkinson's disease and secondary parkinsonism? A nationwide population-based study in Taiwan.

Authors:  Tse-Yen Yang; Feng-Cheng Liu; Zheng-Hao Huang; Hsiang-Cheng Chen; Yu-Ching Chou; Cheng-Li Lin; Chia-Hung Kao; Hsin-Yi Lo
Journal:  BMJ Open       Date:  2018-07-07       Impact factor: 2.692

9.  The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity.

Authors:  Benjamin J Harrison; Gayathri Venkat; James L Lamb; Tom H Hutson; Cassa Drury; Kristofer K Rau; Mary Barlett Bunge; Lorne M Mendell; Fred H Gage; Richard D Johnson; Caitlin E Hill; Eric C Rouchka; Lawrence D F Moon; Jeffrey C Petruska
Journal:  J Neurosci       Date:  2016-04-13       Impact factor: 6.167

10.  Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.

Authors:  S Kuusela; H Wang; A A Wasik; H Suleiman; S Lehtonen
Journal:  Cell Death Dis       Date:  2016-07-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.